183 related articles for article (PubMed ID: 17425679)
1. Aldo-keto reductase family 1, member B10 in uterine carcinomas: a potential risk factor of recurrence after surgical therapy in cervical cancer.
Yoshitake H; Takahashi M; Ishikawa H; Nojima M; Iwanari H; Watanabe A; Aburatani H; Yoshida K; Ishi K; Takamori K; Ogawa H; Hamakubo T; Kodama T; Araki Y
Int J Gynecol Cancer; 2007; 17(6):1300-6. PubMed ID: 17425679
[TBL] [Abstract][Full Text] [Related]
2. Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma.
Sato S; Genda T; Ichida T; Murata A; Tsuzura H; Narita Y; Kanemitsu Y; Ishikawa S; Kikuchi T; Mori M; Hirano K; Iijima K; Wada R; Nagahara A; Watanabe S
J Gastroenterol Hepatol; 2016 Jul; 31(7):1315-22. PubMed ID: 26758591
[TBL] [Abstract][Full Text] [Related]
3. STAR and AKR1B10 are down-regulated in high-grade endometrial cancer.
Sinreih M; Štupar S; Čemažar L; Verdenik I; Frković Grazio S; Smrkolj Š; Rižner TL
J Steroid Biochem Mol Biol; 2017 Jul; 171():43-53. PubMed ID: 28232277
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemistry Detects Increased Expression of Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) in Early-Stage Hepatocellular Carcinoma.
Han C; Gao L; Zhao L; Sheng Q; Zhang C; An Z; Xia T; Ding Y; Wang J; Bai H; Dou X
Med Sci Monit; 2018 Oct; 24():7414-7423. PubMed ID: 30328412
[TBL] [Abstract][Full Text] [Related]
5. Up-regulated aldo-keto reductase family 1 member B10 in chronic hepatitis C: association with serum alpha-fetoprotein and hepatocellular carcinoma.
Sato S; Genda T; Hirano K; Tsuzura H; Narita Y; Kanemitsu Y; Kikuchi T; Iijima K; Wada R; Ichida T
Liver Int; 2012 Oct; 32(9):1382-90. PubMed ID: 22681639
[TBL] [Abstract][Full Text] [Related]
6. High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma.
Wang YY; Qi LN; Zhong JH; Qin HG; Ye JZ; Lu SD; Ma L; Xiang BD; Li LQ; You XM
Sci Rep; 2017 Feb; 7():42199. PubMed ID: 28181486
[TBL] [Abstract][Full Text] [Related]
7. Aldo-keto reductase family 1 B10 gene silencing results in growth inhibition of colorectal cancer cells: Implication for cancer intervention.
Yan R; Zu X; Ma J; Liu Z; Adeyanju M; Cao D
Int J Cancer; 2007 Nov; 121(10):2301-6. PubMed ID: 17597105
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of 14-3-3ε, Aldo-keto Reductase Family 1 B10 and Metallothionein-1 in Hepatocellular Carcinoma.
Wu CY; Jan YJ; Ko BS; Wu YJ; Wu YJ; Liou JY
Anticancer Res; 2018 Dec; 38(12):6855-6863. PubMed ID: 30504401
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas.
Fukumoto S; Yamauchi N; Moriguchi H; Hippo Y; Watanabe A; Shibahara J; Taniguchi H; Ishikawa S; Ito H; Yamamoto S; Iwanari H; Hironaka M; Ishikawa Y; Niki T; Sohara Y; Kodama T; Nishimura M; Fukayama M; Dosaka-Akita H; Aburatani H
Clin Cancer Res; 2005 Mar; 11(5):1776-85. PubMed ID: 15755999
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of AKR1B10 predicts tumor recurrence and short survival in oral squamous cell carcinoma patients.
Fang CY; Lin YH; Chen CL
J Oral Pathol Med; 2019 Sep; 48(8):712-719. PubMed ID: 31237374
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of AKR1B10 in nasopharyngeal carcinoma as a potential biomarker.
He YC; Shen Y; Cao Y; Tang FQ; Tian DF; Huang CF; Tao H; Zhou FL; Zhang B; Song L; He L; Lin LM; Lu FG; Liao DF; Cao D
Cancer Biomark; 2016; 16(1):127-35. PubMed ID: 26835713
[TBL] [Abstract][Full Text] [Related]
12. Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma.
Chung YT; Matkowskyj KA; Li H; Bai H; Zhang W; Tsao MS; Liao J; Yang GY
Mod Pathol; 2012 May; 25(5):758-66. PubMed ID: 22222635
[TBL] [Abstract][Full Text] [Related]
13. High expression of aldo-keto reductase 1B10 is an independent predictor of favorable prognosis in patients with hepatocellular carcinoma.
Ha SY; Song DH; Lee JJ; Lee HW; Cho SY; Park CK
Gut Liver; 2014 Nov; 8(6):648-54. PubMed ID: 25287169
[TBL] [Abstract][Full Text] [Related]
14. [Expression of aldo-keto reductase family 1 member B10 in gastric cancer tissues and its clinical significance].
Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; Tao HQ; Shao QS
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Feb; 16(2):183-7. PubMed ID: 23446484
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication.
Murata A; Genda T; Ichida T; Amano N; Sato S; Tsuzura H; Sato S; Narita Y; Kanemitsu Y; Shimada Y; Hirano K; Iijima K; Wada R; Nagahara A; Watanabe S
World J Gastroenterol; 2016 Sep; 22(33):7569-78. PubMed ID: 27672277
[TBL] [Abstract][Full Text] [Related]
16. Expression of aldo-keto reductase family 1 member b10 in the early stages of human hepatocarcinogenesis.
Tsuzura H; Genda T; Sato S; Murata A; Kanemitsu Y; Narita Y; Ishikawa S; Kikuchi T; Mori M; Hirano K; Iijima K; Wada R; Ichida T
Int J Mol Sci; 2014 Apr; 15(4):6556-68. PubMed ID: 24747592
[TBL] [Abstract][Full Text] [Related]
17. Expression of AKR1B10 as an independent marker for poor prognosis in human oral squamous cell carcinoma.
Ko HH; Cheng SL; Lee JJ; Chen HM; Kuo MY; Cheng SJ
Head Neck; 2017 Jul; 39(7):1327-1332. PubMed ID: 28301069
[TBL] [Abstract][Full Text] [Related]
18. Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
Torres-Mena JE; Salazar-Villegas KN; Sánchez-Rodríguez R; López-Gabiño B; Del Pozo-Yauner L; Arellanes-Robledo J; Villa-Treviño S; Gutiérrez-Nava MA; Pérez-Carreón JI
Dig Dis Sci; 2018 Apr; 63(4):934-944. PubMed ID: 29383608
[TBL] [Abstract][Full Text] [Related]
19. Expression of bcl-2, bax-xL, and bcl-xS in endometrial and cervical tissues.
Mozzetti S; Ferrandina G; Marone M; D'Ingiullo F; Fruscella E; De Pasqua A; Mancuso S; Scambia G
Cancer Detect Prev; 2000; 24(6):536-41. PubMed ID: 11198267
[TBL] [Abstract][Full Text] [Related]
20. Decreased levels of AKR1B1 and AKR1B10 in cancerous endometrium compared to adjacent non-cancerous tissue.
Hevir N; Sinkovec J; Lanišnik Rižner T
Chem Biol Interact; 2013 Feb; 202(1-3):226-33. PubMed ID: 23146748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
